» Articles » PMID: 15197263

Control of Cell Size Through Phosphorylation of Upstream Binding Factor 1 by Nuclear Phosphatidylinositol 3-kinase

Overview
Specialty Science
Date 2004 Jun 16
PMID 15197263
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The insulin-like growth factor I/insulin receptor substrate 1 axis controls, in a nonredundant way, approximately 50% of cell and body size in animals from Drosophila to mice and in cells in culture. Although other factors may also intervene, cell size is strongly dependent on ribosome biogenesis, which is under the control of RNA polymerase I activity. We have previously shown that insulin receptor substrate 1 (IRS-1) translocates to the nuclei and nucleoli, where it binds to the upstream binding factor (UBF) 1, a regulator of RNA polymerase I activity. Activation of UBF1 requires its phosphorylation. However, IRS-1 is not a kinase, and we searched for an intermediate kinase that can phosphorylate UBF1. We demonstrate here that IRS-1 binds also to the phosphatidylinositol 3-kinase (PI3-K) subunits in nuclear extracts, and that the p110 subunit of PI3-K directly phosphorylates and activates UBF1, an exclusively nucleolar protein. The interaction of IRS-1, PI3-K, and UBF1 in the nucleoli provides one of the mechanisms for the effects of IRS-1 on cell and body size.

Citing Articles

Modeling the consequences of age-linked rDNA hypermethylation with dCas9-directed DNA methylation in human cells.

Blokhina Y, Buchwalter A PLoS One. 2024; 19(12):e0310626.

PMID: 39666677 PMC: 11637357. DOI: 10.1371/journal.pone.0310626.


Therapeutic advances of targeting receptor tyrosine kinases in cancer.

Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A Signal Transduct Target Ther. 2024; 9(1):201.

PMID: 39138146 PMC: 11323831. DOI: 10.1038/s41392-024-01899-w.


PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P Effector Signaling in Colorectal Cancer.

Palmieri M, Catimel B, Mouradov D, Sakthianandeswaren A, Kapp E, Ang C Mol Cell Proteomics. 2023; 22(4):100529.

PMID: 36931626 PMC: 10130476. DOI: 10.1016/j.mcpro.2023.100529.


Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium.

Shpakov A, Zorina I, Derkach K Int J Mol Sci. 2023; 24(4).

PMID: 36834685 PMC: 9962062. DOI: 10.3390/ijms24043278.


Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation.

Scalia P, Williams S, Fujita-Yamaguchi Y, Giordano A Cell Cycle. 2022; 22(1):1-37.

PMID: 36005738 PMC: 9769454. DOI: 10.1080/15384101.2022.2108117.


References
1.
Neri L, Borgatti P, Capitani S, Martelli A . The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta. 2002; 1584(2-3):73-80. DOI: 10.1016/s1388-1981(02)00300-1. View

2.
Jorgensen P, Nishikawa J, Breitkreutz B, Tyers M . Systematic identification of pathways that couple cell growth and division in yeast. Science. 2002; 297(5580):395-400. DOI: 10.1126/science.1070850. View

3.
Sun H, Tu X, Prisco M, Wu A, Casiburi I, Baserga R . Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol Endocrinol. 2003; 17(3):472-86. DOI: 10.1210/me.2002-0276. View

4.
Tu X, Baffa R, Luke S, Prisco M, Baserga R . Intracellular redistribution of nuclear and nucleolar proteins during differentiation of 32D murine hemopoietic cells. Exp Cell Res. 2003; 288(1):119-30. DOI: 10.1016/s0014-4827(03)00178-2. View

5.
Hannan K, Brandenburger Y, Jenkins A, Sharkey K, Cavanaugh A, Rothblum L . mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol. 2003; 23(23):8862-77. PMC: 262650. DOI: 10.1128/MCB.23.23.8862-8877.2003. View